Genix Pharmaceuticals Corporation reported earnings results for the second quarter and six months ended April 30, 2024. For the second quarter, the company reported revenue was CAD 0.002913 million compared to CAD 0.008083 million a year ago. Net loss was CAD 0.085943 million compared to CAD 0.234018 million a year ago.
For the six months, revenue was CAD 0.002984 million compared to CAD 0.009665 million a year ago. Net loss was CAD 0.145001 million compared to CAD 0.461055 million a year ago.